Multiple sclerosis: molecular mechanisms and therapeutic opportunities
about
NF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic ImplicationsExpression profiles of cholesterol metabolism-related genes are altered during development of experimental autoimmune encephalomyelitis in the rat spinal cord.Fluctuating vs. continuous exposure to H₂O₂: the effects on mitochondrial membrane potential, intracellular calcium, and NF-κB in astrogliaInhibition of Myeloperoxidase at the Peak of Experimental Autoimmune Encephalomyelitis Restores Blood-Brain-Barrier Integrity and Ameliorates Disease Severity.Novel diagnostic tools and solutions for multiple sclerosis treatment: a patent review (2009 - 2014).Effects of transcranial magnetic stimulation on oxidative stress in experimental autoimmune encephalomyelitis.Further understanding of the immunopathology of multiple sclerosis: impact on future treatments.Application of nanomedicine for crossing the blood-brain barrier: Theranostic opportunities in multiple sclerosis.Nabilone as an adjunctive to gabapentin for multiple sclerosis-induced neuropathic pain: a randomized controlled trial.Myricetin alleviates cuprizone-induced behavioral dysfunction and demyelination in mice by Nrf2 pathway.Pathophysiological Concepts in Multiple Sclerosis and the Therapeutic Effects of Hydrogen Sulfide.Lipopolysaccharide Binding Protein and Oxidative Stress in a Multiple Sclerosis Model.Splitting the "Unsplittable": Dissecting Resident and Infiltrating Macrophages in Experimental Autoimmune Encephalomyelitis.Markers of oxidative/nitrative damage of plasma proteins correlated with EDSS and BDI scores in patients with secondary progressive multiple sclerosis.Serum proteomic analysis of a pre-symptomatic multiple sclerosis cohort.
P2860
Q28078299-F7490077-B84D-42DC-A404-B186988E39B0Q33758896-08D40391-3E39-41CE-BD67-33B4564BB3F3Q35016954-53FFE4A7-D825-4ECE-944D-8F5E2E3B7AC9Q36896738-A187C7F0-9F59-4B85-9197-3B64BE367AE3Q38468023-A375FCED-B0DD-42C6-9B06-790CD8E0D769Q38809422-FEE7AB5D-C377-486D-B375-1F0127084F14Q38837294-5AFD551A-251D-438C-996F-C4587C3018C4Q38896543-737C2DCE-750D-466C-A7A0-01B4A858D253Q39200153-282C95F2-2F79-40F0-9579-1ACAF37B6048Q39314462-84DAC6C4-0567-4A8D-9399-63828B7354CEQ42574092-ED27AED3-8773-4F66-BC7A-0E551788E9FDQ46480272-7A673407-F24C-444C-8522-D42EB79EA75AQ47118345-82E7A99D-AD4B-49E9-BEFD-E8BFBF480F28Q47719110-7876E084-F69C-416B-AF1E-30F7C6641421Q48237116-C09EAEE0-3FB5-4224-9A01-F38D8C43E45B
P2860
Multiple sclerosis: molecular mechanisms and therapeutic opportunities
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Multiple sclerosis: molecular mechanisms and therapeutic opportunities
@ast
Multiple sclerosis: molecular mechanisms and therapeutic opportunities
@en
Multiple sclerosis: molecular mechanisms and therapeutic opportunities
@nl
type
label
Multiple sclerosis: molecular mechanisms and therapeutic opportunities
@ast
Multiple sclerosis: molecular mechanisms and therapeutic opportunities
@en
Multiple sclerosis: molecular mechanisms and therapeutic opportunities
@nl
prefLabel
Multiple sclerosis: molecular mechanisms and therapeutic opportunities
@ast
Multiple sclerosis: molecular mechanisms and therapeutic opportunities
@en
Multiple sclerosis: molecular mechanisms and therapeutic opportunities
@nl
P2860
P3181
P356
P1476
Multiple sclerosis: molecular mechanisms and therapeutic opportunities
@en
P2093
Djordje Miljković
Ivan Spasojević
P2860
P304
P3181
P356
10.1089/ARS.2012.5068
P407
P577
2013-12-20T00:00:00Z